Lung Assessment Device Market Trends

  • Report ID: 5210
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

Lung Assessment Device Market Trends

Growth Drivers

  • Escalating Prevalence of Respiratory Disorders – The escalating incidence of respiratory disorders, such as asthma, chronic obstructive pulmonary disease (COPD), and lung infections, is a driving force behind the expansion of the Lung Assessment Device sector. According to the World Health Organization (WHO), approximately 235 million individuals suffer from asthma globally, and over 3 million deaths are attributed to COPD each year.
  • Growing Emphasis on Early Diagnosis and Prevention: The shift towards proactive healthcare and preventive measures is propelling the demand for lung assessment devices that aid in early diagnosis. Early detection of respiratory conditions allows for timely intervention and better management.
  • Home-based Healthcare and Patient Empowerment: The trend towards home-based healthcare is fostering the development of portable lung assessment devices that empower patients to monitor their respiratory health. This trend is gaining traction, particularly in the wake of the COVID-19 pandemic.

Challenges

  • Technological Complexity and Integration: The rapid evolution of technology, while beneficial, brings forth challenges related to device complexity and seamless integration. Designing and implementing advanced features such as wireless connectivity, real-time data transmission, and user-friendly interfaces require significant engineering expertise. Ensuring compatibility and ease of use across various platforms and devices can be a substantial undertaking.
  • Accuracy and Reliability
  • Regulatory Compliance

Lung Assessment Device Market: Key Insights

Base Year

2024

Forecast Year

2025-2037

CAGR

6.9%

Base Year Market Size (2024)

USD 13.7 billion

Forecast Year Market Size (2037)

USD 32.62 billion

Regional Scope

  • North America (U.S., and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, South Korea, Malaysia, Australia, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 5210
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of lung assessment device is estimated at USD 15.25 billion.

The lung assessment device market size was over USD 13.7 billion in 2024 and is anticipated to cross USD 32.62 billion by 2037, growing at more than 6.9% CAGR during the forecast period i.e., between 2025-2037. Increasing demand from hospitals will drive the market growth.

Asia Pacific industry is predicted to dominate majority revenue share of 38% by 2037, as the region is dynamic hub of healthcare innovation.

The major players in the market are Philips Healthcare, Medtronic, Masimo Corporation, GE Healthcare, BD (Becton, Dickinson and Company), Smiths Medical, Teleflex Incorporated, Fisher & Paykel Healthcare, Nihon Kohden Corporation, CareFusion Corporation
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample